Subrata Haldar

4.6k citations
40 papers · 3.9k indexed · 2 hit papers · h-index 25
Topics
Cell death mechanisms and regulation (17 papers)Immune Cell Function and Interaction (6 papers)Cancer-related Molecular Pathways (5 papers)
Partner nations
United StatesIndiaItaly

In The Last Decade

Subrata Haldar

39 papers receiving 3.9k citations

Hit Papers

Inactivation of Bcl-2 by phosphorylation.199520262005201519951996200400600

Peers

Subrata Haldar
Comparison fields: 5 of 116
  • Molecular Biology 2.5k
  • Oncology 1.5k
  • Immunology 813
  • Cancer Research 511
  • Pathology and Forensic Medicine 408
Replace Kuen‐Feng Chen with:
Kuen‐Feng Chen Taiwan
Tetsuo Mashima Japan
William H. Chappell United States
Donatella Del Bufalo Italy
Juliane M. Jürgensmeier United States
Jordan S. Fridman United States
Volker Gekeler Germany
Joseph A. Fontana United States
Tarek Abbas United States
Kristopher A. Sarosiek United States
Subrata Haldar relative to Kuen‐Feng Chen Taiwan Kuen‐Feng Chen's profile →
Citations per field
00.5×1.5×
Kuen‐Feng Chen · 1×
Citations per year

Countries citing papers authored by Subrata Haldar

Since Specialization
Citations

This map shows the geographic impact of Subrata Haldar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subrata Haldar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subrata Haldar more than expected).

Fields of papers citing papers by Subrata Haldar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subrata Haldar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subrata Haldar. The network helps show where Subrata Haldar may publish in the future.

Co-authorship network of co-authors of Subrata Haldar

This figure shows the co-authorship network connecting the top 25 collaborators of Subrata Haldar. A scholar is included among the top collaborators of Subrata Haldar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subrata Haldar. Subrata Haldar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 7
3
Modulation of MicroRNAs by Chemical Carcinogens and Anticancer Drugs in Human Cancer: Potential Inkling to Therapeutic Advantage.
6
4 51
5 176
6 18
7 148
8 53
9 61
10 36
11 57
12 86
13 26
14 363
15
Taxol induces bcl-2 phosphorylation and death of prostate cancer cells.breakdown →
569
16 40
17 18
18 38
19 20
20 82

About Subrata Haldar

Subrata Haldar is a scholar working on Applied Microbiology and Biotechnology, Oncology and Immunology, having authored 40 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (17 papers), Immune Cell Function and Interaction (6 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Oncology (1.5k citations), Immunology (813 citations) and Molecular Biology (2.5k citations). Subrata Haldar has collaborated with scholars based in United States, India and Italy. Frequent co-authors include C M Croce, Carlo M. Croce, Nilamani Jena, Aruna Basu, John C. Reed, Maria Monne, Massimo Negrini, Silvia Sabbioni, Suparna Qanungo and William E. Carson. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026